Home 9 All Videos 9 NOACs in patients with atrial fibrillation: Insights from the cardiac cath lab – ESC Congress 2020: The Digital Experience

NOACs in patients with atrial fibrillation: Insights from the cardiac cath lab – ESC Congress 2020: The Digital Experience

October 29, 2020

Chairpersons

John William Eikelboom (Hamilton, Canada)

Dominick Joseph Angiolillo (Jacksonville, United States of America)

Subtitle

Sponsored by Boehringer Ingelheim

Learning objectives

Describe the latest data on non-Vitamin K antagonist oral anticoagulants (NOACs) in patients with atrial fibrillation requiring ablation or percutaneous coronary intervention (PCI). Apply practical guidance on dual versus triple antithrombotic therapy.

Presentations

Setting the scene: safety, efficacy, and reversal.

Speaker: John William Eikelboom (Hamilton, Canada)

 

Finding order in complexity: dual versus triple antithrombotic therapy post-PCI.

Speaker: Dominick Joseph Angiolillo (Jacksonville, United States of America)

 

Antithrombotic therapy post-PCI: applying evidence from RE-DUAL PCI to challenging cases.

Speaker: Jurrien M ten Berg (Nieuwegein, Netherlands (The)

 

Practical tips on uninterrupted NOACs in atrial fibrillation ablation.

Speaker: Dhiraj Gupta (Liverpool, United Kingdom of Great Britain & Northern Ireland), John William Eikelboom (Hamilton, Canada)

 

Panel discussion and audience questions: NOACs in cardiology settings.

Speaker: John William Eikelboom (Hamilton, Canada), Dominick Joseph Angiolillo (Jacksonville, United States of America)

 

 

0 Comments

Newsletter

Keep up to date with our latest
articles and journals